InotivNOTVQ -9.91% OCF Yield % is 101.72 as of Jun. 24, 2026, which is 2570% above its 10-year median of 3.81. The stock has 4 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Inotiv ranks better than 99.53% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Inotiv's OCF Yield % or its related term are showing as below:
NOTVQ'
s OCF Yield % Range Over the Past 10 Years
Min: -126.98 Med: 3.81 Max: 145.08
Current: 101.72
During the past 13 years, the highest OCF Yield % of Inotiv was 145.08%. The lowest was -126.98%. And the median was 3.81%.
NOTVQ's OCF Yield % is ranked better than 99.53% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.09
vs NOTVQ: 101.72
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Inotiv OCF Yield % Related Terms
Inotiv OCF Yield % Historical Data
* Premium members only.
The historical data trend for Inotiv's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Inotiv's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inotiv OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Inotiv's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inotiv (NOTVQ) has a OCF Yield % of 101.72 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Inotiv and its competitors. This is 2570% above median its historical median of 3.81. According to the industry distribution chart, Inotiv ranks #1 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 0.5%.
Is Inotiv's OCF Yield % too high?
Inotiv's current OCF Yield % of 101.72 is 2570% above median its 10-year median of 3.81. The Medical Diagnostics & Research industry median OCF Yield % is 1.09. Inotiv's value of 101.72 is 9232.1% above this industry median. Based on the distribution chart, Inotiv ranks #1 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Inotiv's OCF Yield % compare to NDRA and XWEL?
According to the Medical Diagnostics & Research industry distribution chart, Inotiv ranks #1 out of 215 companies for OCF Yield %. This places Inotiv in the top 1% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.09. Inotiv's value of 101.72 is 9232.1% above this benchmark. While the company's 10-year median is 3.81 vs. the industry median of 1.09, Inotiv has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.09, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inotiv's current OCF Yield % of 101.72 is 9232.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Inotiv and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inotiv's current OCF Yield % is 101.72, which is 2570% above median its own 10-year median of 3.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inotiv stock overvalued right now?
Based on GuruFocus' analysis, Inotiv (NOTVQ) is currently considered Possible Value Trap. The stock's GF Value™ is $1.68, compared to a current price of $0.01 — trading 99.4% below its estimated fair value. The current OCF Yield % is 101.72, which is 2570% above median its 10-year median of 3.81 and 9232.1% above the Medical Diagnostics & Research industry median of 1.09. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Inotiv (NOTVQ), the current OCF Yield % is 101.72 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NOTVQ has been successfully added to your 